LTR Pharma Limited (ASX:LTP)
Australia · Delayed Price · Currency is AUD 0.5350
-0.0150 (-2.73%)
At close: Jan 29, 2026
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 97.22 million as of January 29, 2026. Its market cap has decreased by -27.89% in one year.
Market Cap
97.22M
Enterprise Value
65.42M
Revenue
1.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.54
Market Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 97.22M, an increase of 83.51%. That is a compound annual growth rate of 32.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 97.22M | -25.66% |
| Dec 31, 2025 | 130.78M | -10.78% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
| Dec 11, 2023 | 52.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Paradigm Biopharmaceuticals | 136.55M |
| Arovella Therapeutics | 108.11M |
| Island Pharmaceuticals | 100.89M |
| Imugene | 97.53M |
| Proteomics International Laboratories | 94.12M |
| Alterity Therapeutics | 87.00M |
| EZZ Life Science Holdings | 86.32M |
| Radiopharm Theranostics | 81.52M |